{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:45:12Z","timestamp":1790009112330,"version":"4.0.1"},"reference-count":34,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Inherited thrombophilia (IT) increases the risk of adverse pregnancy outcomes, but the benefit of low-molecular-weight heparin (LMWH) prophylaxis remains debated. This study aimed evaluate the effect of LMWH by analyzing outcomes in women with IT who received LMWH versus those who did not and also compare pregnancy complication rates before and after inherited thrombophilia diagnosis. Materials and Methods: We conducted a retrospective case\u2013control study including 276 pregnant women with inherited thrombophilia and prior pregnancy complications and 276 healthy pregnant controls on delivery. The main outcome was the incidence of complications: preterm rupture of membranes, oligohydramnios, fetal growth restriction, preterm delivery, stillbirth, HELLP syndrome, gestational hypertension, deep vein thrombosis, and recurrent pregnancy loss. The effect of LMWH was assessed by comparing complication rates among inherited thrombophilia patients who received therapy versus those who did not. Results: Women with IT were older, had higher BMI, delivered earlier, and had neonates with lower birth weight compared to controls. In current pregnancies, LMWH was associated with reduced rates of preterm delivery, fetal growth restriction, gestational hypertension, and recurrent pregnancy loss, especially in factor V Leiden carriers. LMWH had little effect on low-risk genotypes and was not independently associated with outcome reduction. Conclusions: LMWH prophylaxis should be reserved for high-risk women with IT. Routine use in all IT pregnancies is not justified and may cause unnecessary risks and costs. Early screening, risk stratification, and individualized care are essential to optimize outcomes.<\/jats:p>","DOI":"10.3390\/medicina61071131","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:37:21Z","timestamp":1750739841000},"page":"1131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case\u2013Control Study"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4788-4707","authenticated-orcid":false,"given":"Dragana","family":"Maglic","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"},{"name":"Department for High-Risk Pregnancies, University Clinic for Gynecology and Obstetrics \u201cNarodni Front\u201d, Kraljice Natalije 62, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0005-8443","authenticated-orcid":false,"given":"Vesna","family":"Mandic-Markovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"},{"name":"Department for High-Risk Pregnancies, University Clinic for Gynecology and Obstetrics \u201cNarodni Front\u201d, Kraljice Natalije 62, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4247-3290","authenticated-orcid":false,"given":"Zeljko","family":"Mikovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"},{"name":"Department for High-Risk Pregnancies, University Clinic for Gynecology and Obstetrics \u201cNarodni Front\u201d, Kraljice Natalije 62, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6125-0973","authenticated-orcid":false,"given":"Rastko","family":"Maglic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"},{"name":"Department for High-Risk Pregnancies, University Clinic for Gynecology and Obstetrics \u201cNarodni Front\u201d, Kraljice Natalije 62, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radomir","family":"Anicic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"},{"name":"Department for High-Risk Pregnancies, University Clinic for Gynecology and Obstetrics \u201cNarodni Front\u201d, Kraljice Natalije 62, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Mandic","sequence":"additional","affiliation":[{"name":"Department for High-Risk Pregnancies, University Clinic for Gynecology and Obstetrics \u201cNarodni Front\u201d, Kraljice Natalije 62, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3897\/jbcr.e123690","article-title":"Thromboprophylaxis during pregnancy for prevention of adverse complications in patients with inherited thrombophilia: A literature review","volume":"17","author":"Kirovakov","year":"2024","journal-title":"JBCR"},{"key":"ref_2","first-page":"44","article-title":"Hereditary thrombophilia","volume":"90","author":"Dautaj","year":"2019","journal-title":"Acta Biomed."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2298\/GENSR1602609T","article-title":"The frequencies of FV Leiden and FII G20210A mutations in patients with different clinical manifestations of venous thromboembolism: Experience from a large Serbian cohort","volume":"48","author":"Tomic","year":"2016","journal-title":"Genetika"},{"key":"ref_4","first-page":"e17185","article-title":"Factor V Leiden G1691A and Prothrombin Gene G20210A mutations on pregnancy outcome","volume":"13","author":"Padda","year":"2021","journal-title":"Cureus"},{"key":"ref_5","first-page":"948","article-title":"The incidence of the factor V Leiden mutation in an obstetric population and associated pregnancy outcomes","volume":"192","author":"Nelson","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000274012","article-title":"Thrombophilia in women with pregnancy-associated complications: Fetal loss and pregnancy-related venous thromboembolism","volume":"69","author":"Kovac","year":"2010","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2478\/bjmg-2014-0073","article-title":"The 3\u2032 end prothrombin gene variants in Serbian patients with idiopathic thrombophilia","volume":"17","author":"Aradjanski","year":"2015","journal-title":"Balkan J. Med. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/sjecr-2017-0070","article-title":"Uticaj genskih varijanti FV Leiden, FII G20210A, MTHFR C677T i PAI-1 4G\/5G na gubitke trudno\u0107a kod \u017eena iz centralne Srbije","volume":"21","author":"Sosic","year":"2020","journal-title":"Serbian J. Exp. Clin. Res."},{"key":"ref_9","first-page":"2411","article-title":"Maternal inherited thrombophilia and pregnancy outcomes","volume":"20","author":"Voicu","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Samfireag, M., Potre, C., Potre, O., Tudor, R., Hoinoiu, T., and Anghel, A. (2022). Approach to thrombophilia in pregnancy: A narrative review. Medicina, 58.","DOI":"10.3390\/medicina58050692"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ajo.12393","article-title":"Venous thromboembolism prophylaxis during and following caesarean section: A survey of clinical practice","volume":"56","author":"Seeho","year":"2016","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1701-2163(15)30569-7","article-title":"Venous thromboembolism and antithrombotic therapy in pregnancy","volume":"36","author":"Chan","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: A systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_14","unstructured":"ESHRE Recurrent Pregnancy Loss Guideline Development Group (2023). Recurrent Pregnancy Loss: Guideline of the European Society of Human Reproduction and Embryology, ESHRE. Available online: https:\/\/www.eshre.eu\/Guidelines-and-Legal\/Guidelines\/Recurrent-pregnancy-loss."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2015-12-626739","article-title":"A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia","volume":"127","author":"Skeith","year":"2016","journal-title":"Blood"},{"key":"ref_16","unstructured":"Amaraneni, A., Chippa, V., Goldin, J., and Varacallo, M. (2025, June 01). Anticoagulation Safety, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519025\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"28418","DOI":"10.3390\/ijms161226104","article-title":"Thrombophilia and Pregnancy Complications","volume":"16","author":"Simcox","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics (2018). ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy. Obstet. Gynecol., 132, e1\u2013e17.","DOI":"10.1097\/AOG.0000000000002706"},{"key":"ref_19","unstructured":"Royal College of Obstetricians and Gynaecologists (2015). Reducing the Risk of Venous Thromboembolism During Pregnancy and the Puerperium, RCOG. Green-top Guideline No. 37a."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5734\/JGM.2019.16.1.23","article-title":"First Korean case of factor V Leiden mutation in pregnant woman with a history of recurrent pregnancy loss","volume":"16","author":"Han","year":"2019","journal-title":"J. Genet. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wawrusiewicz-Kurylonek, N., Kr\u0119towski, A.J., and Posmyk, R. (2020). Frequency of thrombophilia-associated gene variants: A population-based study. BMC Med. Genet., 21.","DOI":"10.1186\/s12881-020-01136-5"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: A randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Thomas, O., Lybeck, E., Strandberg, K., Tynng\u00e5rd, N., and Sch\u00f6tt, U. (2015). Monitoring low molecular weight heparins at therapeutic levels: Dose-responses of, and correlations and differences between aPTT, anti-factor Xa and thrombin generation assays. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116835"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jtha.2024.09.029","article-title":"Thrombotic complications in pregnancy: A case-based review of the evidence","volume":"23","author":"Merz","year":"2024","journal-title":"J Thromb. Haemost."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3349\/ymj.2016.57.5.1230","article-title":"The impact of inherited thrombophilia types and low molecular weight heparin treatment on pregnancy complications in women with previous adverse outcome","volume":"57","author":"Aracic","year":"2016","journal-title":"Yonsei Med. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/jog.15319","article-title":"Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta-analysis","volume":"48","author":"Chen","year":"2022","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e16883","DOI":"10.1097\/MD.0000000000016883","article-title":"Comparison of 2 approaches in management of pregnant women with inherited thrombophilias: Prospective analytical cohort study","volume":"98","author":"Dugalic","year":"2019","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wysocka, U., Sa\u0142aci\u0144ska, K., Pinkier, I., K\u0119pczy\u0144ski, \u0141., A\u0142aszewski, W., Dudarewicz, L., and Gach, A. (2023). To Test or Not to Test: Routine Thrombophilia Diagnostic Screening of Women with Reproductive Failures. J. Clin. Med., 12.","DOI":"10.3390\/jcm12247527"},{"key":"ref_29","first-page":"1653","article-title":"Genetic predisposition to thrombophilia in women with reproductive failure in Serbian population","volume":"35","author":"Subotic","year":"2018","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Women\u2019s Health Care Physicians (2013). ACOG Practice Bulletin No. 138: Inherited thrombophilias in pregnancy. Obstet. Gynecol., 122, 706\u2013717.","DOI":"10.1097\/01.AOG.0000433981.36184.4e"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/14647273.2016.1255785","article-title":"Genetics of suspected thrombophilia in Serbian females with infertility, including three cases, homozygous for FII 20210A or FV 1691A mutations","volume":"20","author":"Djurovic","year":"2017","journal-title":"Hum. Fertil."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1373\/49.7.1081","article-title":"Plasminogen activator inhibitor 1 4G\/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: Impaired fibrinolysis and early pregnancy loss","volume":"49","author":"Dossenbach","year":"2003","journal-title":"Clin. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: A meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"ref_34","unstructured":"Institut Pasteur (2023). Thrombophilia and Pregnancy\u2014Preventing Maternal and Placental Thrombosis: Guidelines, Institut Pasteur."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:57:30Z","timestamp":1760032650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071131"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071131","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}